NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

TSX · Drug Manufacturers - Specialty & Generic · CAD

Auxly Cannabis Group Inc. (XLY.TO) Stock Analysis

Auxly Cannabis Group Inc. (XLY.TO) is a Drug Manufacturers - Specialty & Generic stock listed on TSX and quoted in Canadian Dollar.

XLY.TO

CA$3.18

+CA$0.01 (+0.32%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare XLY.TO with… →

XLY.TO Key Statistics

As of Sep 4, 2026
Trading
Open
CA$3.18
Previous Close
CA$3.17
Day's Range
3.11–3.18
52-Week Range
1.54–3.30
Volume
26.10K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
1.23
Valuation
Market Cap
CA$328.29M
P/E Ratio
10.26
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
13.79
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
1.98
EPS (ttm)Profit attributable to each share over the last twelve months.
0.31
Financials (FY)
Profit marginThe share of revenue left as profit after all costs and taxes.
19.69%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
103.24M
1-Year Return
+2093.10%
Dividend and dates
Earnings Date
November 12, 2026
Avg Volume
97.03K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

XLY.TO Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+2093.10%
2025+262.50%
2024+300.00%
2023−50.00%
2022−89.19%
2021−27.45%
2020−52.78%
2019−40.66%
2018 (partial year)−30.27%

As of September 4, 2026.

XLY.TO Valuation vs Drug Manufacturers - Specialty & Generic Median

Median of 103 stocks
MetricXLY.TODrug Manufacturers - Specialty & Generic medianvs median
P/E10.2619.2747% below
P/S ratio1.982.3014% below
Profit margin19.69%−3.14%22.8 pts above

Medians across 103 Drug Manufacturers - Specialty & Generic stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Analysis

Data-derived

Company Overview

Auxly Cannabis Group Inc. (XLY.TO) is capitalised at CA$328.29M on the latest close. The company sits in the Healthcare sector, in the Drug Manufacturers - Specialty & Generic industry. The company reports 446 employees.

The most recent close on file for XLY.TO is CA$3.18, dated September 4, 2026. That is +CA$0.01 (+0.32%) against the previous close. The 52-week range on file runs from CA$1.54 to CA$3.30. The latest close sits 106.49% above that 52-week low.

Financial Health

Trailing twelve-month revenue on file is CA$165.57M. Profit margin runs at 19.69%. That is 22.8 percentage points above the Drug Manufacturers - Specialty & Generic median of −3.14%. Trailing earnings per share are 0.31.

Valuation Assessment

XLY.TO trades at a trailing price-to-earnings ratio of 10.26. That is 46.74% below the Drug Manufacturers - Specialty & Generic median of 19.27. The forward P/E on file is 13.79. Measured against sales, the shares trade at 1.98 times revenue. On price-to-sales that is 13.65% below the Drug Manufacturers - Specialty & Generic median of 2.3. 103 Drug Manufacturers - Specialty & Generic companies report these metrics, and the medians quoted come from that group.

The trailing one-year price return is +2,093.10%. Across 5 years the annualized return works out at +62.58%. The reported beta is 1.23. Annualized volatility over the trailing 8 years is 498.25%.

Growth & Income

No dividend is on file for XLY.TO.

2026 is still running; the price is +2,093.10% year to date. The strongest complete calendar year on file is 2024 at +300.00%; the weakest is 2022 at −89.19%. Of the 7 complete calendar years on file, 2 finished higher.

Peer Comparison

Auxly Cannabis Group Inc. (XLY.TO) operates in the Drug Manufacturers - Specialty & Generic industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Auxly Cannabis Group Inc. XLY.TO CA$328.29M 10.3
Takeda Pharmaceutical Company Limited TAK CA$58.92B —
Teva Pharmaceutical Industries Limited TEVA CA$42.37B 60.6
Haleon plc HLN CA$42.22B 20.0

The Drug Manufacturers - Specialty & Generic industry average P/E ratio is 19.3x. Auxly Cannabis Group Inc. trades at a P/E of 10.3.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Drug Manufacturers - Specialty & Generic Stocks

TAK

Takeda Pharmaceutical Company Limited

$58.92B

 TEVA

Teva Pharmaceutical Industries Limited

$42.37B

 HLN

Haleon plc

$42.22B

 ZTS

Zoetis Inc.

$31.33B

 UTHR

United Therapeutics Corporation

$20.91B

 VTRS

Viatris Inc.

$19.39B
View all Drug Manufacturers - Specialty & Generic stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

 JNJ

Johnson & Johnson

$663.28B

 ABBV

AbbVie Inc.

$453.19B

 MRK

Merck & Co., Inc.

$370.89B

 UNH

UnitedHealth Group Incorporated

$356.47B
View all Healthcare stocks →

About Auxly Cannabis Group Inc.

Auxly Cannabis Group Inc. operates as a consumer-packaged goods company in the cannabis products market in Canada. The company offers dried and fresh cannabis, plants, seeds, and oils; and edibles, extracts, and topicals under the KOLAB PROJECT, Dosecann, BACK FORTY, Foray, and Parcel brand names. It sells its products through supply arrangements with provincial control boards and distributors, medical cannabis sales channels, and retailers, as well as to authorized wholesalers. The company was formerly known as Cannabis Wheaton Income Corp. and changed its name to Auxly Cannabis Group Inc. in June 2018. Auxly Cannabis Group Inc. was incorporated in 1987 and is headquartered in Toronto, Canada.

Visit website →